Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Ter Heine

Showing results (51-60 of 160) with videos related to

Pageof 16
Sort By:
Biomedical Chromatography : BMC|December 7, 2019
Validation of an analytical method using HPLC-MS/MS to quantify osimertinib in human plasma and supplementary stability resultsArd van Veelen, Robin van Geel, Yvo de Beer, et al.
Clinical Pharmacokinetics|December 29, 2022
Low and Highly Variable Exposure to Prophylactic LMWH Nadroparin in Critically Ill Patients: Back to the Drawing Board for Prophylactic Dosing?Jeroen Diepstraten, Anne van Rongen, Marianne P Zijlstra, et al.
AIDS (London, England)|October 3, 2003
Case series of acute hepatitis in a non-selected group of HIV-infected patients on nevirapine-containing antiretroviral treatmentMonique M de Maat, Rob ter Heine, Eric C M van Gorp, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2018
Pharmacokinetics of Anidulafungin in Obese and Normal-Weight AdultsRoeland E Wasmann, Rob Ter Heine, Eric P van Dongen, et al.
Antiviral Therapy|October 9, 2008
A pharmacokinetic and pharmacogenetic study of efavirenz in children: dosing guidelines can result in subtherapeutic concentrationsRob ter Heine, Henriette J Scherpbier, Kristel M L Crommentuyn, et al.
Biomedical Chromatography : BMC|November 6, 2021
Highly sensitive quantification of pemetrexed in human plasma using UPLC-MS/MS to support microdosing studiesEleonora W J van Ewijk-Beneken Kolmer, Marga J A Teulen, Rene J Boosman, et al.
Drugs|May 18, 2026
Antibody-Drug Conjugates in Non-small Cell Lung CancerLodovica Zullo, Martina Bortolot, Francesca R Ogliari, et al.
British Journal of Clinical Pharmacology|August 26, 2021
The effect of chemotherapy on the exposure-response relation of abiraterone in metastatic castration-resistant prostate cancerEmmy Boerrigter, Guillemette E Benoist, Joanneke K Overbeek, et al.
British Journal of Clinical Pharmacology|April 5, 2014
Population pharmacokinetic modelling to assess the impact of CYP2D6 and CYP3A metabolic phenotypes on the pharmacokinetics of tamoxifen and endoxifenRob ter Heine, Lisette Binkhorst, Anne Joy M de Graan, et al.
International Journal of Cancer|July 24, 2025
Early pembrolizumab clearance as prognostic biomarker for non-response in patients with advanced non-small cell lung cancerFenna de Vries, Leila-Sophie Otten, Berber Piet, et al.
Pageof 16

Showing results (51-60 of 160) with videos related to

Sort By:
Pageof 16
Biomedical Chromatography : BMC|December 7, 2019
Validation of an analytical method using HPLC-MS/MS to quantify osimertinib in human plasma and supplementary stability resultsArd van Veelen, Robin van Geel, Yvo de Beer, et al.
Clinical Pharmacokinetics|December 29, 2022
Low and Highly Variable Exposure to Prophylactic LMWH Nadroparin in Critically Ill Patients: Back to the Drawing Board for Prophylactic Dosing?Jeroen Diepstraten, Anne van Rongen, Marianne P Zijlstra, et al.
AIDS (London, England)|October 3, 2003
Case series of acute hepatitis in a non-selected group of HIV-infected patients on nevirapine-containing antiretroviral treatmentMonique M de Maat, Rob ter Heine, Eric C M van Gorp, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2018
Pharmacokinetics of Anidulafungin in Obese and Normal-Weight AdultsRoeland E Wasmann, Rob Ter Heine, Eric P van Dongen, et al.
Antiviral Therapy|October 9, 2008
A pharmacokinetic and pharmacogenetic study of efavirenz in children: dosing guidelines can result in subtherapeutic concentrationsRob ter Heine, Henriette J Scherpbier, Kristel M L Crommentuyn, et al.
Biomedical Chromatography : BMC|November 6, 2021
Highly sensitive quantification of pemetrexed in human plasma using UPLC-MS/MS to support microdosing studiesEleonora W J van Ewijk-Beneken Kolmer, Marga J A Teulen, Rene J Boosman, et al.
Drugs|May 18, 2026
Antibody-Drug Conjugates in Non-small Cell Lung CancerLodovica Zullo, Martina Bortolot, Francesca R Ogliari, et al.
British Journal of Clinical Pharmacology|August 26, 2021
The effect of chemotherapy on the exposure-response relation of abiraterone in metastatic castration-resistant prostate cancerEmmy Boerrigter, Guillemette E Benoist, Joanneke K Overbeek, et al.
British Journal of Clinical Pharmacology|April 5, 2014
Population pharmacokinetic modelling to assess the impact of CYP2D6 and CYP3A metabolic phenotypes on the pharmacokinetics of tamoxifen and endoxifenRob ter Heine, Lisette Binkhorst, Anne Joy M de Graan, et al.
International Journal of Cancer|July 24, 2025
Early pembrolizumab clearance as prognostic biomarker for non-response in patients with advanced non-small cell lung cancerFenna de Vries, Leila-Sophie Otten, Berber Piet, et al.
Pageof 16